Serological detection of anti HPV 16/18 and its association with pap smear in adolescents and young women;Detecção sorológica de anti-HPV 16 e 18 e sua associação com os achados do papanicolaou em adolescentes e mulheres jovens

Revista da Associacao Medica Brasileira

Volumn 52, Issue 1, 2006, Pages 43-47

  Rama, Cristina Helena ^a,b   Roteli Martins, Cecilia Maria ^b,c   Mauricette Derchain, Sophie Françoise ^c   De Oliveira, Eliane Z ^c   Aldrighi, José Mendes ^a   Neto, Corintio Mariani ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital Leonor M de Barros   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antibodies anti HPV; Colpocitology; Neoplasia; Serology

Indexed keywords

EID: 33646848621     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0104-42302006000100021     Document Type: Article

References (22)

1. Walboomers JMM, Iacobs MV, Mannos MM, Bosch XF, Kummer A, Shah KV, et al. Human papillomavirus, a necessary cause of invasive cervical cancer wordwide. J Pathol 1999;189:12-9.
2. Bosch FX, Munhoz N, Manos MM, Sherman M, Iansen Am, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a wordwide perspective.J Natl Cancer Inst 1995;87:796-802.
3. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM,Rush BB, et al. Epidemiologic evidence showing that Human Papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
4. Bosh FX, Lorinez A, Munoz N, Meyer CJML, Shak KV. The casual relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65.
5. Rozendaal L, Walboomers JM, Van der Linden JC, Voorhort FJ, Kenemans P, Helmerhorst TJ, et al. PCR-based high-risk HPV test in cervical cancer secreening gives objective risk assessment of women with cytomorphologically normal cervical smear. Int J Cancer 1996;68:766-79.
6. Syrjänen K, Mäntyjärvi R, Saarikoski S, Väyrynen M, Syrjänen S, Parkkinen S, et al. Factors associated with progression of cervical human papillomavirus (HPV) infections into carcinoma in situ during a long- term prospective follow-up. Br J Obstet Gynaecol 1988;95 1096-102.
7. [IARC.] Internacional Agency for Research on cancer monograph on the evaluation of carcinogenic riscks to human. Human papillomaviruses, vol. 64 Lyon: 1995.
8. Swygart C.Human papillomavirus: disease and laboratory diagnosis. Br J Biomed Sci 1997;54:299-303.
9. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection young women: a longitudinal cohort study. Lancet 2001;357(9271):1831-6.
10. Beutner KR, Tyring S. Human papillomavirus and human disease. Am J Med 1997;102:9-15.
11. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal pappilomavirus infection in young women. N Engl J Med 1998;338:423-8.
12. Zeferino LC, Amaral RG, Dufloth RM. HPV e a neoplasia do colo do útero. Femina 2002;30:471-5.
13. De Sanjose S, Santamaria M, Alonso de Ruiz P, Aristizabal N, Guerrero E, Castellsague X, et al. HPV types in woman with normal cervical cytology. IARC Sci Publ 1992;119:75-84.
14. Fahey MT, Irwing L, Macaskill P. Meta analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.
15. Stoller MH. Advances in cervical screening tecnology. Mod Pathol 2000;13:275-84.
16. Carvalho JJM, Oyakawa N. Papilomavírus humano. I Consenso Brasileiro de HPV. São Roque; 1999.
17. Carter JJ, Koutsky LA, Wipf GC, Christensen ND, Lee SK, Kuypers J, Kiviat N, Galloway. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 1996;174:927-36.
18. Coursaget P. Serology for human papillomavirus. Salud Publica Mex 2003;45:361-6.
19. Evans TG, Bonnez W, Rose RC, Koenig S, Demeter L, Suzich JÁ, et al. A phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in health adult volunteers. J Infect Dis 2001;183:1485-93.
20. Wideroff L, Schiffman MH, Haderer P, Armstrong A, Geer CE, Manos MM. Seroreactivity to human papillomavirus type 16, 18, 31 and 45 VLP in a case control study of cervical squamous intraephitelial lesions. J Infect Dis 1999;180:1424-8.
21. The 1988 Bethesda system for reporting cervical/ vaginal cytologic diagnosis. Acta Cytol 1988, 567-71.
22. Kinrbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994;86:494-8.